Skip to main content
Clinical Trials/JPRN-UMIN000044728
JPRN-UMIN000044728
Recruiting
N/A

Multi-center observational study on clinicopathological/molecular features and therapeutic effects of immune checkpoint inhibitors in MSI-H/dMMR solid tumors - Multi-center observational study on the immune profiles of MSI-H/dMMR solid tumors

ational Cancer Center0 sites200 target enrollmentJuly 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
MSI-H/dMMR solid tumor
Sponsor
ational Cancer Center
Enrollment
200
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 1, 2021
End Date
December 31, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
ational Cancer Center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) patients judged to be inappropriate by a physician in charge 2\) Excluded from research subjects when there is a refusal to use samples and information (opt\-out) in cases where consent has not been obtained.

Outcomes

Primary Outcomes

Not specified

Similar Trials